UPDATE : Monday, September 7, 2020
상단여백
NOAC race: Pradaxa prescription numbers fall behind fast followers by Marian Chu 2017-09-14 19:02
Opdivo vs. Keytruda - which will doctors choose? by Marian Chu 2017-09-14 17:54
AstraZeneca regains momentum with positive Imfinzi results by Marian Chu 2017-09-14 13:34
Amgen, Chong Kun Dang to sell osteoporosis drug in Korea by Marian Chu 2017-09-13 18:33
Alvogen Korea to sell Vivus’ obesity drug by Marian Chu 2017-09-13 18:16
라인
Opdivo’s expanded indications ease cancer patients’ worries by Marian Chu 2017-09-13 16:57
EU approves Abbvie’s Humira as first biologic to treat CHMP by Marian Chu 2017-09-12 15:45
Lilly’s diabetes drug ahead of Novo Nordisk’s in Q2 market share by Marian Chu 2017-09-12 13:26
Abbvie lands 1st place on Dow Jones Sustainability Index by Marian Chu 2017-09-11 14:38
GSK’s HIV drug ranked No. 1 in Q2 sales by Marian Chu 2017-09-11 14:37
라인
FDA orders halt on Opidvo trials by Marian Chu 2017-09-08 16:39
Give peanut butter to infants to prevent peanut allergy: study by Marian Chu 2017-09-08 11:42
EU grants 1st approval for Siemens' new MRI scanner by Marian Chu 2017-09-07 16:38
Teva-Handok wins approval for anti-asthma injection by Marian Chu 2017-09-07 14:58
Novartis Korea gains approval for skin disease biologic by Marian Chu 2017-09-07 14:28
라인
BMS, Pfizer prove safety for blood-thinning drug in P4 trial by Marian Chu 2017-09-06 17:40
Novartis’ Revolade proved effective for seniors by Marian Chu 2017-09-06 12:53
Will Amgen’s Repatha succeed in the Korean market? by Marian Chu 2017-09-06 09:07
Pfizer Korea releases new tool for rheumatism injection by Marian Chu 2017-09-05 17:22
Celgene Korea names new CEO by Marian Chu 2017-09-05 14:22
여백
여백
여백
Back to Top